In vivo and in vitro measurement of CYP2C19 activity

Methods in Enzymology

Volumn 272, Issue , 1996, Pages 105-114

  Wedlund, Peter J ^a   Wilkinson, Grant R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4' HYDROXYMEPHENYTOIN; 5 HYDROXYOMEPRAZOLE; CYTOCHROME C2; MEPHENYTOIN; OMEPRAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CONVULSION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HYDROXYLATION; PHENOTYPE; PRIORITY JOURNAL; SEDATION; STEREOSPECIFICITY;

EID: 0029775811     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0076-6879(96)72013-x     Document Type: Article

References (22)

1. G. R. Wilkinson, F. P. Guengerich, and R. A. Branch, Pharmacol. Ther. 43, 53 (1989).
2. J. A. Goldstein and J. Blaisdell, Methods Enzymol. 272, Chap. 23, 1996 (this volume).
3. A. Küpfer and R. Preisig, Eur. J. Clin. Pharmacol. 26, 753 (1984).
4. P. J. Wedlund, W. S. Aslanian, C. B. McAllister, G. R. Wilkinson, and R. A. Branch, Clin. Pharmacol. Ther. 36, 773 (1984).
5. P. J. Wedlund, W. S. Aslanian, E. Jacqz, C. B. McAllister, R. A. Branch, and G. R. Wilkinson, J. Pharmacol. Exp. Ther. 234, 662 (1985).
6. E. Sanz, T. Villén, C. Alm, and L. Bertilsson, Clin. Pharmacol. Ther. 45, 495 (1989).
7. K. Nakamura, F. Goto, W. A. Ray, C. B. McAllister, E. Jacqz, G. R. Wilkinson, and R. A. Branch, Clin. Pharmacol. Ther. 38, 402 (1985).
8. J. D. Balian, N. Sukhova, J. W. Harris, J. Hewett, L. Pickle, J. A. Goldstein, R. L. Woosley, and D. A. Flockhart, Clin. Pharmacol. Ther. 57, 662 (1995).
9. R. Setiabudy, K. Chiba, M. Kusaka, and T. Ishizaki, Br. J. Clin. Pharmacol. 33, 665 (1992).
10. E. Jacqz, S. D. Hall, R. A. Branch, and G. R. Wilkinson, Clin. Pharmacol. Ther. 39, 646 (1986).
11. P. J. Wedlund, B. J. Sweetman, G. R. Wilkinson, and R. A. Branch, Drug Metab. Dispos. 15, 277 (1987).
12. Y. Zhang, R. A. Blouin, P. J. McNamara, J. Steinmetz, and P. J. Wedlund, Br. J. Clin. Pharmacol. 31, 350 (1991).
13. G. Tybring and L. Bertilsson, Pharmacogenetics 2, 241 (1992).
14. P. A. Arns, D. Ryder, L. White, G. R. Wilkinson, and R. A. Branch, Pharmacologist 32, 140 (1990).
15. T. Andersson, C.-G. Regårdh, Y.-C. Lou, Y. Zhang, M.-L. Dahl, and L. Bertilsson, Pharmacogenetics 2, 25 (1992).
16. D.-R. Sohn, K. Kobayashi, K. Chiba, K.-H. Lee, S.-G. Shin, and T. Ishizaki, J. Pharmacol. Exp. Ther. 262, 1195 (1992).
17. M. Chang, G. Tybring, M.-L. Dahl, E. Götharson, M. Sagar, R. Seensalu, and L. Bertilsson, Br. J. Clin. Pharmacol. 39, 511 (1995).
18. M. Chang, M.-L. Dahl, G. Tybring, E. Götharson, and L. Bertilsson, Pharmacogenetics 5, 358 (1995).
19. D. J. Birkett, T. Andersson, and J. O. Miners, Methods Enzymol. 272, Chap. 14, 1996 (this volume).
20. T. Shimada, J. P. Shea, and F. P. Guengerich, Anal. Biochem. 147, 174 (1985).
21. W. R. Brian, P. K. Srivastava, D. R. Umbenhauer, R. S. Lloyd, and F. P. Guengerich, Biochemistry 28, 4993 (1989).
22. J. A. Goldstein, M. B. Faletto, M. Romkes-Sparks, T. Sullivan, S. Kitareewan, J. L. Raucy, J. M. Lasker, and B. I. Ghanayem, Biochemistry 33, 1743 (1994).